Posts Tagged ‘hep c’

Observing National Hepatitis Testing Day

Observing National Hepatitis Testing Day Dr. Ronald Valdiserri Next Monday, May 19th, is the third national Hepatitis Testing Day, established to raise greater awareness of an epidemic that is too often unrecognized. Millions Living with Undiagnosed Infections There are approximately 3.5–5.3 million Americans living with chronic viral hepatitis, but most of them do not know…

Read More

Medicare Eases Restrictions On Pricey Hepatitis C Treatment

Medicare Eases Restrictions On Pricey Hepatitis C Treatment By Richard Knox Alexandra Olgin for NPR This policy change would pay for treatment with a combination of new, expensive drugs for patients who haven’t responded to older treatment regimens and are approaching or have cirrhosis of the liver. Friday, May 16, 2014 Federal Medicare officials are…

Read More

The cure for hepatitis C is upon us

The cure for hepatitis C is upon us, but at a costly penny ANDRÉ PICARD (Corrected version) The Globe and Mail Published Sunday, Apr. 27 2014, 4:00 PM EDT Last updated Sunday, Apr. 27 2014, 10:33 PM EDT There is a revolution coming to the treatment of hepatitis C. But a big fat asterisk is…

Read More

Liver Care After Successful Hepatitis C Treatment

Liver Care After Successful Hepatitis C Treatment March 19, 2014 Being cured of Hepatitis C is an exciting and more frequent occurrence thanks to improvements in antiviral therapy; however, caring for your liver afterwards is important for the liver’s longevity. By Nicole Cutler L.Ac. One of your most precious internal organs, the liver takes a…

Read More

FDA approves OLYSIO (simeprevir) for treatment of chronic hepatitis C infection

FDA approves OLYSIO (simeprevir)  Janssen Therapeutics, Division of Janssen Products, LP (Janssen), announced today the U.S. Food and Drug Administration (FDA) has approved OLYSIO™ (simeprevir), an NS3/4A protease inhibitor, for the treatment of chronic hepatitis C infection as part of an antiviral treatment regimen in combination with pegylated interferon and ribavirin in genotype 1 infected…

Read More

FDA approves new treatment for hepatitis C virus

FDA approves new treatment for hepatitis C virus FDA NEWS RELEASE For Immediate Release: Nov. 22, 2013 Media Inquiries: Stephanie Yao, 301-796-0394, stephanie.yao@fda.hhs.gov Consumer Inquiries: 888-INFO-FDA FDA approves new treatment for hepatitis C virus The U.S. Food and Drug Administration today approved Olysio (simeprevir), a new therapy to treat chronic hepatitis C virus infection. Hepatitis…

Read More

Sofosbuvir taken before or after liver transplant reduces hepatitis C recurrence

Sofosbuvir taken before or after liver transplant reduces hepatitis C recurrence Liz Highleyman An interferon-free combination of sofosbuvir plus ribavirin administered before liver transplantation prevented hepatitis C recurrence in nearly two-thirds of patients, while the same regimen led to early viral clearance in three-quarters of those treated after transplantation, according to studies presented this week…

Read More

Curing Hepatitis C

Curing Hepatitis C BALTIMORE, Md. (Ivanhoe Newswire) — Hepatitis C is the most common bloodborne viral infection in the US, affecting more than 4-million people. The deadly disease can lead to cirrhosis of the liver and liver cancer. Now there is a new era of hepatitis-c drugs that could cure the disease, without side effects.…

Read More

What is Viral Load?

What is Viral Load? by: Albrecht Ernst Your viral load is the amount of specific viruses that you have, in a given volume of your blood (usually 1 milliliter = 1 cubic centimeter). More precisely, it means that the amount of Hep C genetic material found in your blood corresponds to as many Hep C…

Read More